Skip to content
ClinCalc Pro
Menu
Antibiotic (Penicillin) Pregnancy: Amoxicillin may be used in pregnancy when the potential benefits outweigh the potential risks associated with treatment; animal studies do not indicate reproductive toxicity and limited human data do not indicate an increased risk of congenital malformations. Breastfeeding: excreted into breast milk in small quantities with a possible risk of sensitisation, so diarrhoea and fungal infection of the mucous membranes are possible in the breast-fed infant and breast-feeding might have to be discontinued — use only after a benefit/risk assessment by the physician in charge (§4.6).

Amoxicillin

Brand names: Amoxil

Used in: Pneumonia COPD Urinary Tract Infection Meningitis & Encephalitis

Amoxicillin is a broad-spectrum aminopenicillin antibiotic for respiratory, ENT, urinary and other infections, and part of Helicobacter pylori regimens.

Auto-extracted from the source labelling — not yet independently clinician-verified. These values were distilled from the UK SPC (or the US label where noted) but have not had a clinician sign-off. Confirm against the current SmPC before prescribing.

Adult dose

Dose: 250 mg to 500 mg every 8 hours, or 750 mg to 1 g every 12 hours (adults and children weighing 40 kg or more) — the dose is indication-dependent, see notes
Route: Oral — absorption is unimpaired by food. Therapy can be started parenterally according to the dosing recommendations of the intravenous formulation and continued with an oral preparation.
Frequency: Every 8 hours or every 12 hours depending on indication and dose selected
Max: No single overall adult maximum is stated in §4.2. The highest stated ceilings are for Lyme disease — up to a maximum of 4 g/day in divided doses (early stage) and up to a maximum of 6 g/day in divided doses (late stage with systemic involvement).
SOURCE: eMC UK SPC, productName 'Amoxicillin 250 mg/5 ml Powder for Oral Suspension Sugar Free' (https://www.medicines.org.uk/emc/product/14145/smpc), §4.2. The dose selected should take into account the expected pathogens and their likely susceptibility, the severity and site of the infection, and the age, weight and renal function of the patient. TABLE-FLATTENING CAVEAT: the fetched text flattens the SPC's two-column dose table, so every indication/dose pairing below must be confirmed against the table in the SPC itself before publishing. INDICATION-SPECIFIC ADULT DOSES (adults and children 40 kg or more), as listed: acute bacterial sinusitis, asymptomatic bacteriuria in pregnancy, acute pyelonephritis, dental abscess with spreading cellulitis — 250 mg to 500 mg every 8 hours or 750 mg to 1 g every 12 hours, and for severe infections 750 mg to 1 g every 8 hours; acute cystitis — may be treated with 3 g twice daily for one day; acute otitis media, acute streptococcal tonsillitis and pharyngitis, acute exacerbations of chronic bronchitis — 500 mg every 8 hours or 750 mg to 1 g every 12 hours, and for severe infections 750 mg to 1 g every 8 hours for 10 days; community acquired pneumonia — 500 mg to 1 g every 8 hours; typhoid and paratyphoid fever — 500 mg to 2 g every 8 hours; prosthetic joint infections — 500 mg to 1 g every 8 hours; prophylaxis of endocarditis — 2 g orally as a single dose 30 to 60 minutes before the procedure; Helicobacter pylori eradication — 750 mg to 1 g twice daily in combination with a proton pump inhibitor (e.g. omeprazole, lansoprazole) and another antibiotic (e.g. clarithromycin, metronidazole) for 7 days; Lyme disease early stage — 500 mg to 1 g every 8 hours up to a maximum of 4 g/day in divided doses for 14 days (10 to 21 days); Lyme disease late stage with systemic involvement — 500 mg to 2 g every 8 hours up to a maximum of 6 g/day in divided doses for 10 to 30 days. Consideration should be given to the official treatment guidelines for each indication. DURATION should be determined by the type of infection and the response of the patient and should generally be as short as possible. PAEDIATRIC (children weighing under 40 kg) — deliberately NOT structured into paedDose because the SPC gives indication-dependent RANGES rather than a single per-kg value, and a single figure would be an invention: acute bacterial sinusitis, acute otitis media, community acquired pneumonia, acute cystitis, acute pyelonephritis, dental abscess with spreading cellulitis — 20 to 90 mg/kg/day in divided doses; acute streptococcal tonsillitis and pharyngitis — 40 to 90 mg/kg/day in divided doses; typhoid and paratyphoid fever — 100 mg/kg/day in three divided doses. Twice daily dosing regimens should only be considered when the dose is in the upper range. Children weighing 40 kg or more should be prescribed the adult dosage. Amoxicillin paediatric suspension is recommended for children under six months of age. Verify all paediatric dosing against a children's formulary. ELDERLY: no dose adjustment is considered necessary. HEPATIC IMPAIRMENT: dose with caution and monitor hepatic function at regular intervals. SOURCE NOTE: §4.5 was not captured in this bundle (the §4.4 text is truncated at the source-fetch limit) and the openFDA provider is empty, so no interactions list is asserted in this draft — the clinician must review §4.5 in the SPC.

Dose adjustments

Renal

§4.2: GFR greater than 30 ml/min — no adjustment necessary (adults, children 40 kg or more, and children under 40 kg). GFR 10 to 30 ml/min — adults and children 40 kg or more: maximum 500 mg twice daily; children under 40 kg: 15 mg/kg given twice daily. GFR less than 10 ml/min — adults and children 40 kg or more: maximum 500 mg/day; children under 40 kg: 15 mg/kg given as a single daily dose. In the majority of cases parenteral therapy is preferred for children under 40 kg. HAEMODIALYSIS — adults and children over 40 kg: 500 mg every 24 hours, with one additional 500 mg dose prior to haemodialysis and another 500 mg after haemodialysis to restore circulating drug levels; children under 40 kg: 15 mg/kg/day as a single daily dose (maximum 500 mg), with an additional 15 mg/kg before and 15 mg/kg after haemodialysis. PERITONEAL DIALYSIS: maximum 500 mg/day.

Dose auto-extracted from UK Summary of Product Characteristics (SPC) via the eMC — not yet clinician-verified. Always confirm against the product SmPC and your local formulary before prescribing.

US labelling (FDA)

Reference — US labelling, may differ from UK

Adults and Pediatric Patients greater than 40 kg: 500 or 875 mg every 12 hours or 250 or 500 mg every 8 hours, based on the amoxicillin component. ( 2.2 , 2.3 ) Pediatric patients aged 12 weeks (3 months) and older: 25 to 45 mg/kg/day every 12 hours or 20 to 40 mg/kg/day every 8 hours, up to the adult dose. ( 2.3 ) Neonates and infants less than 12 weeks of age: 30 mg/kg/day divided every 12 hours, based on the amoxicillin component. Use of the 125 mg/5 mL oral suspension is recommended. ( 2.3 ) 2.1 Important Administration Instructions Amoxicillin and Clavulanate Potassium may be taken without regard to meals; however, absorption of clavulanate potassium is enhanced when Amoxicillin and …

Source: US FDA prescribing information (openFDA / DailyMed), label dated 2024-04-30. Accessed 2026-06-12. US dosing and indications can differ from UK practice — use UK sources for prescribing decisions.

Contraindications

  • Hypersensitivity to the active substance, to any of the penicillins, or to any of the excipients
  • History of a severe immediate hypersensitivity reaction (e.g. anaphylaxis) to another beta-lactam agent (e.g. a cephalosporin, carbapenem or monobactam)

Side effects

  • Diarrhoea and nausea (common) — the most commonly reported reactions, with vomiting (uncommon)
  • Skin rash (common); urticaria and pruritus (uncommon)
  • Severe allergic reactions including angioneurotic oedema, anaphylaxis, serum sickness and hypersensitivity vasculitis (very rare); Kounis syndrome (not known); Jarisch-Herxheimer reaction after treatment of Lyme disease (not known)
  • Severe cutaneous reactions — erythema multiforme, Stevens-Johnson syndrome, toxic epidermal necrolysis, bullous and exfoliative dermatitis, acute generalised exanthematous pustulosis (AGEP) and DRESS (very rare)
  • Antibiotic associated colitis including pseudomembranous and haemorrhagic colitis, hepatitis and cholestatic jaundice, interstitial nephritis, crystalluria including acute renal injury, reversible leucopenia, thrombocytopenia and haemolytic anaemia, hyperkinesia, dizziness and convulsions (very rare); aseptic meningitis (not known)

Clinical monograph

How it works

A beta-lactam that inhibits bacterial cell-wall synthesis by binding penicillin-binding proteins.

Prescribing in practice

  • Avoid in penicillin allergy.
  • It commonly causes a non-allergic rash if given during glandular fever (infectious mononucleosis).
  • Like other antibiotics it can predispose to Clostridioides difficile and, rarely, hypersensitivity.

Monitoring

Short courses need no routine monitoring; review the response.

Counselling the patient

  • Complete the course.
  • Report a rash, wheeze or facial swelling (possible allergy).
  • Report severe or prolonged diarrhoea.

Evidence & guidelines

A first-line antibiotic for many community infections (NICE/local antimicrobial guidance).

Reference: NICE NG138 (Pneumonia); PHE Antibiotic Guidelines; Drug verified in RxNorm (NLM); confirm dosing against the manufacturer SPC (eMC). Verify against your local formulary and current prescribing references before prescribing. The structured dose values shown have been reviewed by a clinician. Monograph status: clinician-reviewed (2026-07-04).

Related

Curated clinical cross-links plus same-class fallbacks.